|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 256.56 USD | -0.04% |
|
+1.46% | +50.92% |
| Aug. 06 | Jazz Pharmaceuticals Insider Sold Shares Worth $1,517,880, According to a Recent SEC Filing | MT |
| Aug. 05 | UBS Adjusts Jazz Pharmaceuticals Price Target to $315 From $307, Maintains Buy Rating | MT |
| Market Cap | 16.65B 14.41B 13.45B 12.34B 23.21B 1,585B 23.58B 158B 61.95B 794B 62.54B 61.17B 2,626B | P/E 2026 * |
18.1x | P/E 2027 * | 16.2x |
|---|---|---|---|---|---|
| Enterprise Value | 18.21B 15.75B 14.71B 13.5B 25.38B 1,733B 25.79B 173B 67.74B 869B 68.39B 66.89B 2,872B | EV / Sales 2026 * |
3.87x | EV / Sales 2027 * | 3.31x |
| Free-Float |
96.78% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Jazz Pharmaceuticals plc
| 1 day | -0.04% | ||
| 1 week | +1.46% | ||
| Current month | +1.46% | ||
| 1 month | +3.57% | ||
| 3 months | +13.04% | ||
| 6 months | +55.02% | ||
| Current year | +50.92% |
| 1 week | 247.42 |  | 265.04 |
| 1 month | 233.46 | | 265.04 |
| Current year | 156.95 | | 265.04 |
| 1 year | 110.26 | | 265.04 |
| 3 years | 95.49 | | 265.04 |
| 5 years | 95.49 | | 265.04 |
| 10 years | 86.88 | | 265.04 |
| Manager | Title | Age | Since |
|---|---|---|---|
Renée Galá
CEO | Chief Executive Officer | 54 | 2025-08-10 |
Philip Johnson
DFI | Director of Finance/CFO | 62 | 2024-02-29 |
Mary Henderson
CTO | Chief Tech/Sci/R&D Officer | 54 | 2023-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Bruce Cozadd
CHM | Chairman | 62 | 2003-02-28 |
Seamus Mulligan
BRD | Director/Board Member | 65 | 2012-01-17 |
Rick Winningham
BRD | Director/Board Member | 66 | 2009-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/3/26 | Sell | Founder | -6,000 | 0.0096% | ||
| 7/1/26 | Sell | Founder | -6,000 | 0.0096% | ||
| 6/30/26 | Tax | Executive/Senior Manager | -2,527 | 0.0040% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.04% | +1.46% | +128.91% | +95.09% | 16.65B | |
| -0.52% | +3.21% | +85.02% | +161.12% | 1,057B | |
| +0.88% | +1.13% | +51.13% | +49.76% | 625B | |
| +0.89% | -1.95% | +23.73% | +63.67% | 435B | |
| +0.71% | +3.87% | +47.45% | +38.68% | 363B | |
| +0.64% | -0.49% | +35.39% | +40.21% | 296B | |
| +0.39% | -5.83% | +8.64% | +9.28% | 249B | |
| +1.51% | +6.69% | +44.34% | +62.47% | 222B | |
| +3.92% | -0.46% | -1.21% | -44.09% | 209B | |
| +1.80% | +2.30% | +20.79% | +65.13% | 165B | |
| Average | +1.18% | +0.93% | +44.42% | +54.13% | 363.74B | |
| Weighted average by Cap. | +1.12% | +1.22% | +48.71% | +75.43% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.71B 4.07B 3.8B 3.49B 6.56B 448B 6.67B 44.61B 17.51B 225B 17.68B 17.29B 742B | 4.97B 4.3B 4.02B 3.68B 6.93B 473B 7.04B 47.13B 18.5B 237B 18.67B 18.26B 784B |
| Net income | 975M 843M 787M 722M 1.36B 92.75B 1.38B 9.24B 3.63B 46.49B 3.66B 3.58B 154B | 1.12B 971M 907M 832M 1.56B 107B 1.59B 10.64B 4.18B 53.55B 4.22B 4.12B 177B |
| Net Debt | 1.56B 1.35B 1.26B 1.15B 2.17B 148B 2.2B 14.76B 5.79B 74.28B 5.85B 5.72B 246B | -175M -151M -141M -130M -244M -16.65B -248M -1.66B -651M -8.34B -657M -643M -27.59B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-07 | $256.56 | -0.04% | 970,711 |
| 26-08-06 | $256.65 | -1.88% | 804,491 |
| 26-08-05 | $261.57 | -0.02% | 715,291 |
| 26-08-04 | $261.62 | +3.99% | 1,895,188 |
| 26-08-03 | $251.58 | -0.51% | 1,493,478 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- JAZZ Stock
Select your edition
All financial news and data tailored to specific country editions
